Exercise Program of Breast Cancer Patients Undergoing Chemotherapy With or Without Radiation

Sponsor
Memorial Sloan Kettering Cancer Center (Other)
Overall Status
Completed
CT.gov ID
NCT01157767
Collaborator
(none)
90
1
135.4
0.7

Study Details

Study Description

Brief Summary

The purpose of this study is to study if a patients follows an exercise program specifically designed for them during the time of their treatment after surgery. Their ability to follow the program and its influence on their weight maintenance and early post-operative lymphedema rates will also be studied. Lymphedema is a condition in which excess fluid collects in tissue and causes swelling of the arm(s).

Condition or Disease Intervention/Treatment Phase
  • Other: standardized regimen of exercises, including a warm-up period, ROM arm exercises, and strength training exercises.

Study Design

Study Type:
Observational
Actual Enrollment :
90 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Feasibility Study of the Effects of a Directed Exercise Program of Breast Cancer Patients Undergoing Chemotherapy With or Without Radiation
Actual Study Start Date :
May 11, 2010
Actual Primary Completion Date :
Aug 23, 2021
Actual Study Completion Date :
Aug 23, 2021

Arms and Interventions

Arm Intervention/Treatment
breast pts who have undergone surgery

This will be a feasibility study designed to evaluate the compliance of an at-home, directed exercise program and its influence on physical measures during post-operative adjuvant chemotherapy and radiation (if applicable).

Other: standardized regimen of exercises, including a warm-up period, ROM arm exercises, and strength training exercises.
Module I is a group of arm movements. It consists of stretching exercises coordinated with breathing exercises to restore their physical mobility, range of motion and flexibility of shoulders. Module I is to be performed daily. In Module II the exercises are a series of copyrighted, sequential movements designed to put the body in proper alignment. It is a special series of muscle movements to help establish better body alignment, as well as increased strength and flexibility of one's arms, legs, and spine, each exercise is 4 repetitions. Module III is the walking and the resistance weight training program. The walking program is whole body exercise, multi-joint, weight-bearing, low impact and for beginners to advanced.

Outcome Measures

Primary Outcome Measures

  1. To evaluate compliance with and demonstrate the feasibility of an at-home, directed exercise program during adjuvant chemotherapy and radiation (if applicable). [2 years]

Secondary Outcome Measures

  1. To describe how this exercise program affects weight maintenance and percent body fat during adjuvant chemotherapy and radiation. [2 years]

  2. To describe how this exercise program affects early post-operative lymphedema rates, monitoring the strength training specifics -including the number of repetitions and sets of each exercise, frequency, and order of exercises. [2 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients will be eligible if they have any of the following surgical procedures performed by an attending on the Breast Service:

SLNB alone Axillary lymph node dissection (ALND) alone Total Mastectomy TM (+/- reconstruction) with SLNB or ALND Breast conserving therapy (BCT) with SLNB or ALND

  • Age > 18 years

  • Planned to undergo adjuvant post-operative chemotherapy with or without radiation at MSKCC and have not yet started chemotherapy

Exclusion Criteria:
  • Undergoing TM or BCT without SLNB

  • Having had prior breast cancer treated with surgery

  • Unable to participate in a exercise program related to other medical problems

  • More than 8 weeks post surgery.

  • Having a concurrent cancer in addition to breast cancer

  • Who have had any type of chemotherapy in the past two years

Contacts and Locations

Locations

Site City State Country Postal Code
1 Memorial Sloan Kettering Cancer Center New York New York United States 10065

Sponsors and Collaborators

  • Memorial Sloan Kettering Cancer Center

Investigators

  • Principal Investigator: Alexandra Heerdt, MD, MPH, Memorial Sloan Kettering Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01157767
Other Study ID Numbers:
  • 10-062
First Posted:
Jul 7, 2010
Last Update Posted:
Sep 1, 2021
Last Verified:
Aug 1, 2021
Keywords provided by Memorial Sloan Kettering Cancer Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 1, 2021